Richard /ca/ Murray, CEO and President at Jounce Therapeutics, Inc. (JNCE), sold 32,668 shares at $25.10 ($820K) on 2018-03-08, disclosed to the SEC on 2018-03-12.
Open-market sale of $820k JNCE by CEO and President. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $25.10 | 16,334 | $410K | 50.0% |
| 2 | $25.10 | 16,334 | $410K | 50.0% |
| Total | $25.10 avg | 32,668 | $820K | 100% |
| Filing → |
| JNCE | SELL | 2022-01-11 | $416K | — | Filing → |
| JNCE | SELL | 2021-01-25 | $808K | — | Filing → |
| JNCE | SELL | 2021-01-20 | $1.3M | — | Filing → |